Papadopoulos, N., Szefler, S., Bacharier, L., Maspero, J., Domingo, C., Fiocchi, A., . . . Rowe, P. (2023). Assessment of dupilumab in children with moderate-to-severe type 2 asthma with or without evidence of allergic asthma.
Citación estilo ChicagoPapadopoulos, NG, et al. Assessment of Dupilumab in Children With Moderate-to-severe Type 2 Asthma With or Without Evidence of Allergic Asthma. 2023.
Cita MLAPapadopoulos, NG, et al. Assessment of Dupilumab in Children With Moderate-to-severe Type 2 Asthma With or Without Evidence of Allergic Asthma. 2023.
Precaución: Estas citas no son 100% exactas.